Condition: Maculopapular Lesion
rs13287547
in
C9orf92
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs78239784
in
CFHR4
gene and
Maculopapular Lesion
PMID 29288229
2018 Genetic variation in
CFH
predicts phenytoin-induced maculopapular exanthema in European-descent patients.
rs1429264
in
COTL1
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs79007183
in
CRAMP1
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs62270313
in
EPHB1
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs1178326
in
HDAC9
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs9596863
in
LINC00558
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs631844
in
LINC02109;LOC107986410
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs75078187
in
LOC100506422
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs74308953
in
LOC102724929
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs970510
in
LOC102725148
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs139427007
in
LOC105369927;LOC105369928
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs55949311
in
LOC105370210
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs12668095
in
LOC105375268
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs7495694
in
LOC107984801
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs150435906
in
LOC107986950
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
rs141860749
in
SYT2
gene and
Maculopapular Lesion
PMID 26220383
2015 GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.